Valuation: DocMorris AG

Market Cap 425M 526M 460M 393M 746M 50.24B 758M 5.08B 1.99B 24.67B 1.98B 1.93B 85.46B P/E 2026 *
-5.69x
P/E 2027 * -10.8x
Enterprise Value 626M 776M 679M 579M 1.1B 74.05B 1.12B 7.49B 2.94B 36.36B 2.91B 2.85B 126B EV / Sales 2026 *
0.51x
EV / Sales 2027 * 0.48x
Free-Float
66.58%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 27/04/2022
Director of Finance/CFO 56 30/09/2024
Chief Tech/Sci/R&D Officer - 31/10/2024
Director TitleAgeSince
Chairman 68 27/04/2022
Director/Board Member 53 22/05/2019
Director/Board Member 56 31/12/2020
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 546M
-1.42%+7.44%-18.69%-5.53% 6.11B
-0.49%+5.83%-18.46%-34.22% 3.61B
-4.34%-2.83%-38.74%-11.08% 3.2B
-1.02%-1.92%-29.42%-46.88% 3.21B
-0.90%+9.29%+3.34%-35.18% 2.98B
+0.10%+4.23%-17.89%-0.64% 2.54B
+1.66%-2.24%+94.69% - 2.56B
-0.86%-2.45%-1.41%+39.42% 1.67B
-8.05%-10.62%-32.30%-43.12% 1.55B
Average -10.31%+0.68%-6.54%-17.15% 3.05B
Weighted average by Cap. -3.04%+1.90%-8.93%-18.12%

Financials

2026 *2027 *
Net sales 1.22B 1.51B 1.32B 1.13B 2.14B 144B 2.18B 14.6B 5.73B 70.86B 5.68B 5.55B 245B 1.37B 1.7B 1.49B 1.27B 2.41B 162B 2.45B 16.42B 6.44B 79.67B 6.38B 6.24B 276B
Net income -83.51M -104M -90.55M -77.26M -147M -9.88B -149M -1B -392M -4.85B -389M -380M -16.81B -46.79M -58M -50.74M -43.29M -82.16M -5.54B -83.54M -560M -220M -2.72B -218M -213M -9.42B
Net Debt 201M 249M 218M 186M 353M 23.81B 359M 2.41B 945M 11.69B 936M 916M 40.5B 238M 296M 259M 221M 419M 28.21B 426M 2.86B 1.12B 13.85B 1.11B 1.09B 47.98B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
8.685CHF
Average target price
7.756CHF
Spread / Average Target
-10.69%

Quarterly revenue - Rate of surprise